A cool way to make proteins

Article Abstract:

The 'pCold' vector system when utilized at the right temperature reduces the expression of endogenous bacterial proteins and it might also reduce the various problems put together. Once this cold shock is performed the bacterial cells change to machines that produce protein and is dedicated solely to creating recombinant protein.

Manufacturing processes, Risk factors, Production processes, Proteins, Varieties, Recombinant proteins

---

New antibiotics from bacterial natural products

Article Abstract:

The naturally occurring antibiotics from both new and old sources are rediscovered with unique scaffolds and novel mechanisms of action. The newly discovered antibiotics would provide valuable clues about the bacterial targets against which natural product and synthetic chemical libraries should be screened.

---

Beyond interferon

Article Abstract:

Interferon (IFN)-alpha has ruled as the biotech antiviral market since its identification fifty years ago. However, the various antibody treatments and nucleic acid therapies targeting cellular proteins and viral components by the new generation biotech firm may change the scenario.

Usage, Interferon alpha

Similar abstracts:

• Abstracts: Agency costs and the performance implications of international joint venture internalization. An empirical test of heuristics and biases affecting real option valuation
• Abstracts: Recombinant protein folding and misfolding in Escherichia coli
• Abstracts: Do central banks lose on foreign-exchange intervention? A review article. New evidence on the Fed's productivity in providing payments services
• Abstracts: Win a scholarship to Oxford. Excellence in corporate finance. In defense of the European Commission
• Abstracts: A framework for managing system disturbances and insights from air traffic management

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.